IMPROVING THE EFFICACY OF DOCETAXEL-BASED CHEMOTHERAPY FOR HORMONE-REFRACTORY PROSTATE CANCER USING THE NOVEL MECHANISM OF XIAP DEPLETION

The Institute For Cancer Research

Investigators